You Have Options

Introducing Liqrev® (sildenafil) and Tadliq® (tadalafil)
for treating patients with Pulmonary Arterial Hypertension (PAH)

Click the tabs below for treatment options

This website is for healthcare providers

Please click on the agreement button below to acknowledge that you are a healthcare provider.

Have questions? Call CMP Support Services
1-844-267-0001
Download Prescription Request Form Download Prescription Request Form
Menu

Dosing Guide

  1. Home |
  2. Resources |
  3. Dosing Guide
Tadliq® and the stylized Tadliq® logo are registered trademarks of CMP Development LLC. Tadliq is marketed by CMP Pharma, Inc. © 2023 CMP Pharma, Inc. All rights reserved.